Percutaneous closure of left atrial appendage to prevent embolic events in high‐risk patients with chronic atrial fibrillation
- 27 April 2009
- journal article
- valvular and-structural-heart-diseases
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 74 (2) , 217-222
Abstract
Background: Percutaneous closure of the left atrial appendage (LAA) is a novel alternative for the treatment of patients with atrial fibrillation (AF) and with a high risk of stroke who are not eligible for long‐term anticoagulation therapy. The aim of this study was to asses the safety, feasibility, and long‐term efficacy of this procedure.Methods: From July 2004 to June 2007, 20 patients (13 male, mean age 69 ± 8 years) with non–valvular AF (NV‐AF) underwent LAA percutaneous closure using the PLAATO™ system, implanted through a transeptal access. All patients had contraindications to anticoagulant therapy and were at high risk for cardioembolic stroke (mean CHADS2 score 3 ± 1.2). A trans‐thoracic echocardiogram was performed at 1, 3, and every 6 months after the procedure, whereas a trans‐oesophageal echocardiogram (TOE) was scheduled at 6 months. After 24 months, a phone interview was obtained.Results: All procedures were successfully performed in 18 patients. In two patients, LAA closure was not feasible for the presence of a multilobed LAA. Two patients underwent percutaneous closure of patent foramen ovale in the same session. In one patient, the procedure was complicated by cardiac perforation with pericardial effusion, treated with pericardiocentesis. At a mean follow up of 40 ± 10 months, no embolic events occurred. One patient died, after 36 months, for gastric cancer. TOE examination showed the complete exclusion of the LAA in all patients.Conclusions: Percutaneous closure of LAA is safe and efficacious to prevent stroke in patients with NV‐AF at high risk for cardioembolic events, with contraindications to anticoagulant therapy.Keywords
This publication has 20 references indexed in Scilit:
- Clinical outcomes three years after PLAATO implantationCatheterization and Cardiovascular Interventions, 2007
- Left Atrial Appendage Exclusion and the Risk of Thromboembolic Events Following Mitral Valve SurgeryJournal of Cardiovascular Electrophysiology, 2007
- ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm SocietyEP Europace, 2006
- Percutaneous left atrial appendage transcatheter occlusion in patients with chronic nonvalvular atrial fibrillation: early institutional experienceJournal of Cardiovascular Medicine, 2006
- Percutaneous Left Atrial Appendage Transcatheter Occlusion (PLAATO System) to Prevent Stroke in High-Risk Patients With Non-Rheumatic Atrial FibrillationJACC, 2005
- Left atrial structure and function after percutaneous left atrial appendage transcatheter occlusion (PLAATO)JACC, 2004
- Surgical left atrial appendage ligation is frequently incomplete: a transesophageal echocardiographic studyJACC, 2000
- Transesophageal Echocardiographic Correlates of Thromboembolism in High-Risk Patients with Nonvalvular Atrial FibrillationAnnals of Internal Medicine, 1998
- Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillationThe Annals of Thoracic Surgery, 1996
- Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.Stroke, 1991